Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: A longitudinal study

The Lancet Neurology

Volumn 13, Issue 5, 2014, Pages 482-489

  Velázquez Pérez, Luis ^a   Rodríguez Labrada, Roberto ^a   Canales Ochoa, Nalia ^a   Montero, Jacqueline Medrano ^a   Sánchez Cruz, Gilberto ^a   Aguilera Rodríguez, Raúl ^a   Almaguer Mederos, Luis E ^a   Laffita Mesa, José M ^a  

^a Centro para la Investigacion y Rehabilitacion de las Ataxias Hereditarias Cuba   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ACTION POTENTIAL; ADOLESCENT; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CAG REPEAT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HYPOREFLEXIA; LATENT PERIOD; LONGITUDINAL STUDY; MALE; MEDIAN NERVE; MUSCLE CRAMP; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROLOGIC EXAMINATION; ONSET AGE; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; SENSORY DYSFUNCTION; SENSORY NERVE CONDUCTION; SIBLING; SPINOCEREBELLAR ATAXIA TYPE 2; SPINOCEREBELLAR DEGENERATION; SURAL NERVE; TIBIAL NERVE;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; CUBA; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROLOGIC EXAMINATION; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 84898431140     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70027-4     Document Type: Article

References (30)

1. Pulst MS, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996, 14:269-276.
2. Velázquez-Pérez L, Cruz GS, Santos Falcon N, et al. Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguín. Neurosci Lett 2009, 454:157-160.
3. Sequeiros J, Martins S, Silveira I Epidemiology and population genetics of degenerative ataxias. Handbook of clinical neurology, volume 103, 3rd series. Ataxic Disorders 2012, 227-251. Elsevier, Amsterdam. N.-S.H. Subramo, A. Durr (Eds.).
4. Schöls L, Bauer P, Schmidt T, Schulte T, Riess O Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet 2004, 3:291-304.
5. Velázquez-Pérez L, Rodríguez-Labrada R, García-Rodríguez JC, Almaguer-Mederos LE, Cruz-Mariño T, Laffita-Mesa JM A comprehensive review of spinocerebellar ataxia type 2 in Cuba. Cerebellum 2011, 10:184-198.
6. Underwood BR, Rubinsztein DC Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies. Cerebellum 2008, 7:215-221.
7. Velázquez-Pérez L, Sanchez Cruz G, Canales Ochoa N, et al. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. J Neurol Sci 2007, 263:158-164.
8. Velázquez-Pérez L, Seifried C, Abele M, et al. Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2. Clin Neurophysiol 2009, 120:632-635.
9. Rodriguez-Labrada R, Velázquez-Pérez L, Canales-Ochoa N, et al. Subtle REM sleep abnormalities in presymptomatic spinocerebellar ataxia type 2 gene carriers. Mov Disord 2011, 26:347-350.
10. Velázquez-Pérez, Rodriguez-Labrada R Preclinical neurodegeneration of olfactory system in asymptomatic SCA2 mutation carriers. Early manifestation of spinocerebellar ataxia type 2. From physioptahology to preclinical biomarkers 2012, 97-104. Ediciones Holguín, Holguín. L. Velázquez-Pérez (Ed.).
11. Velázquez-Pérez L, Díaz R, Pérez-González R, et al. Motor decline in presymptomatic Spinocerebellar ataxia type 2 gene carriers. PLoS One 2009, 4:5398-5402.
12. Velazquez-Perez L, Rodriguez-Labrada R, Canales-Ochoa N, et al. Progression markers of Spinocerebellar ataxia 2. A twenty years neurophysiological follow up study. J Neurol Sci 2010, 290:22-26.
13. World Medical Association declaration of helsinki ethical principles for medical research involving human subjects. JAMA 2013, 310:2191-2194. World Medical Association.
14. Denny-Brown D, Dawson DM, Tyler HR Handbook of neurological examination and case recording 1982, Harvard University Press, Cambridge, Mass. 3rd edn.
15. Santos-Anzorandia C The ABC of the clinic electroneuromyography 2003, ECIMED, La Habana, (in Spanish). 1st edn.
16. DeLisa JA, Lee HJ, Baran EM, Lai K, Spielholz N Manual of nerve conduction velocity and clinical neurophysiology 1994, Raven Press, NY. 3rd edn.
17. Miller T, Layzer RB Muscle cramps. Muscle Nerve 2005, 32:431-442.
18. Layzer RB The origin of muscle fasciculations and cramps. Muscle Nerve 1994, 17:1243-1249.
19. Kanai K, Kuwabara S Motor nerve hyperexcitability and muscle cramps in Machado-Joseph disease. Arch Neurol 2009, 66:139.
20. Velázquez-Pérez L, Rodriguez-Labrada R, Medrano-Montero J, et al. Electromyographic pattern in patients and asymptomatic carriers of the SCA2 mutation. Rev Neurol 2009, 49:55-56. (in Spanish).
21. Jacobi H, Reetz K, Tezenas du Montcel S, et al. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet 2013, 12:650-658.
22. Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies characterize it as an olivo-ponto-cerebellar atrophy (OPCA) plus. Acta Neuropathol 1999, 97:306-310.
23. Kuwabara S, Ogawara K, Koga M, Mori M, Hattor T, Yuki N Hyper reflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatr 1999, 67:180-184.
24. Ragno M, Perretti AC, Castaldo I, et al. Multimodal electrophysiologic follow-up study in 3 mutated but presymptomatic members of a spinocerebellar ataxia type 1 (SCA1) family. Neurol Sci 2005, 26:67-71.
25. Klockgether T The clinical diagnosis of autosomal dominant spinocerebellar ataxias. Cerebellum 2008, 7:101-105.
26. Manto MU The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 2005, 4:2-6.
27. Stolze H, Klebe S, Petersen G, et al. Typical features of cerebellar ataxic gait. J Neurol Neurosurg Psychiatry 2002, 73:310-312.
28. Grimaldi G, Manto M Topography of cerebellar deficits in humans. Cerebellum 2011, 11:336-351.
29. Inagaki A, Iida A, Matsubara M, Inagaki H Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals. Eur J Neurol 2005, 12:725-728.
30. Gierga K, Burk K, Bauer M, et al. Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol 2005, 109:617-631.